Select Language
COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Specialty Generics Market: Introduction
4.1 What are Specialty Generic Drugs?
4.2 Types of Specialty Generics
5 Why are Specialty Generics So Lucrative?
6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Market Breakup by Route of Administration
6.4 Market Breakup by Therapeutic Application
6.5 Market Breakup by Distribution Channel
6.6 Market Breakup by Region
6.7 Market Forecast
7 US Specialty Generics Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Route of Administration
7.5 Market Breakup by Therapeutic Application
7.6 Market Breakup by Distribution Channel
7.7 Market Forecast
7.8 SWOT Analysis
7.8.1 Overview
7.8.2 Strengths
7.8.3 Weaknesses
7.8.4 Opportunities
7.8.5 Threats
7.9 Value Chain Analysis
7.10 Porters Five Forces Analysis
7.10.1 Overview
7.10.2 Bargaining Power of Buyers
7.10.3 Bargaining Power of Suppliers
7.10.4 Degree of Competition
7.10.5 Threat of New Entrants
7.10.6 Threat of Substitutes
7.11 Key Market Drivers and Success Factors
8 Market Breakup by Route of Administration
8.1 Injectables
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.1 Market Forecast
9 Market Breakup by Therapeutic Application
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hepatitis
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Multiple Sclerosis
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 HIV
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Other Autoimmune Diseases
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Retail Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Specialty Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Hospital Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
List of Figures
Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 3: Global: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2020
Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 7: US: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 8: US: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 9: US: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2020
Figure 10: US: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 11: US: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 12: US: Specialty Generics Industry: SWOT Analysis
Figure 13: US: Specialty Generics Industry: Value Chain Analysis
Figure 14: US: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 15: US: Specialty Generics Market (Administration through Injectables): Sales Value (in Million US$), 2015 & 2020
Figure 16: US: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: US: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2015 & 2020
Figure 18: US: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: US: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2015 & 2020
Figure 20: US: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: US: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2015 & 2020
Figure 22: US: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: US: Specialty Generics Market (Hepatitis): Sales Value (in Million US$), 2015 & 2020
Figure 24: US: Specialty Generics Market (Hepatitis) Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: US: Specialty Generics Market (Multiple Sclerosis): Sales Value (in Million US$), 2015 & 2020
Figure 26: US: Specialty Generics Market (Multiple Sclerosis) Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: US: Specialty Generics Market (HIV): Sales Value (in Million US$), 2015 & 2020
Figure 28: US: Specialty Generics Market (HIV) Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: US: Specialty Generics Market (Other Autoimmune Diseases): Sales Value (in Million US$), 2015 & 2020
Figure 30: US: Specialty Generics Market (Other Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: US: Specialty Generics Market (Other Applications): Sales Value (in Million US$), 2015 & 2020
Figure 32: US: Specialty Generics Market (Other Applications) Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: US: Specialty Generics Market: Sales Through Retail Pharmacies (in Million US$), 2015 & 2020
Figure 34: US: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Million US$), 2021-2026
Figure 35: US: Specialty Generics Market: Sales Through Specialty Pharmacies (in Million US$), 2015 & 2020
Figure 36: US: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Million US$), 2021-2026
Figure 37: US: Specialty Generics Market: Sales Through Hospital Pharmacies (in Million US$), 2015 & 2020
Figure 38: US: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Million US$), 2021-2026
List of Tables
Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 2: US: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 3: US: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 4: US: Specialty Generics Market Forecast: Breakup by Therapeutic Application (in Million US$), 2021-2026
Table 5: US: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: US: Specialty Generics Market: Competitive Structure
Table 7: US: Specialty Generics Market: Key Players
The United States specialty generics market was valued at US$ 21 Billion in 2020.
We expect the United States specialty generics market to exhibit a CAGR of around 10% during 2021-2026.
The increasing prevalence of various life-threatening diseases, such as cancer, multiple sclerosis, hepatitis, HIV, etc., is one of the factors driving the United States specialty generics market.
With the outbreak of the COVID-19 in the United States, there is a significant rise in the R&D activities pertaining to specialty generic drugs for combating the spread of coronavirus infection.
Based on the route of administration, the United States specialty generics market can be segmented into injectables, oral, and others. Currently, injectables hold the majority of the total market share.
Based on the therapeutic application, the United States specialty generics market has been segregated into oncology, multiple sclerosis, hepatitis, HIV, other autoimmune diseases, and others, where oncology currently represents the largest segment.
Based on the distribution channel, the United States specialty generics market can be categorized into retail pharmacies, specialty pharmacies, and hospital pharmacies. Currently, retail pharmacies exhibit a clear dominance in the market.
10% Free customization
Purchase Options
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at
sales@imarcgroup.com